SLC12A5 and schizophrenia: We did not find any changes in KCC2 expression in the haloperidol treated rats, suggesting that the decrease in KCC2 protein expression is not due to a medication effect, and that the absence of a decrease in KCC2 protein levels in medicated subjects with schizophrenia is a disease by treatment interaction (Fig 1B).